Literature DB >> 16876987

Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.

Yoshie Masaoka1, Yusuke Tanaka, Makoto Kataoka, Shinji Sakuma, Shinji Yamashita.   

Abstract

This study was conducted to assess the site of drug absorption in the gastrointestinal (GI) tract after oral administration. Drug permeability to different regions of rat intestine, jejunum, ileum and colon, was measured by in situ single-pass perfusion method. It was revealed that the epithelial surface area should not be a determinant of the regional difference in the intestinal permeability of highly permeable drugs. Effects of the mucus layer at the surface of the epithelium and the fluidity of the epithelial cell membrane on the drug permeability were investigated. These factors are demonstrated to contribute to the regional differences in intestinal drug permeability. The luminal drug concentration in each segment of the GI tract after oral administration was measured directly in fasted rats. Water ingested orally was absorbed quickly in the jejunum and the luminal fluid volume was diminished in the middle to lower part of the small intestine. According to the absorption of water luminal concentration of atenolol, a drug with low permeability, was elevated and exceeded the initial dose concentration. In contrast, the concentration of highly permeable drugs, antipyrine and metoprolol, decreased quickly in the upper part of the intestine and a significant amount of drugs was not detected in the lower jejunum and the ileum. From the time-profiles of luminal drug concentration, fraction of dose absorbed from each segment of the GI tract was calculated. Both antipyrine and metoprolol were found to be absorbed quickly at the upper part of the small intestine. In addition, the possible contribution of gastric absorption was demonstrated for these drugs. The pattern of site-dependent absorption of atenolol showed the higher absorbability in the middle and lower portion of the jejunum. These informations on site-dependent absorption of drugs are considered to be important for effective oral delivery systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876987     DOI: 10.1016/j.ejps.2006.06.004

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  31 in total

1.  A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations.

Authors:  Matthew F Crum; Natalie L Trevaskis; Hywel D Williams; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2015-12-24       Impact factor: 4.200

2.  Permeation of four oral drugs through human intestinal mucosa.

Authors:  Erina Pretorius; Patrick J D Bouic
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

3.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

Review 4.  Predicting and Understanding the Human Microbiome's Impact on Pharmacology.

Authors:  Reese Hitchings; Libusha Kelly
Journal:  Trends Pharmacol Sci       Date:  2019-06-03       Impact factor: 14.819

5.  Measurement of drug concentration in the stomach after intragastric administration of drug solution to healthy volunteers: analysis of intragastric fluid dynamics and drug absorption.

Authors:  Shinji Yamashita; Makoto Kataoka; Haruki Higashino; Shinji Sakuma; Takashi Sakamoto; Hinako Uchimaru; Hiroshi Tsukikawa; Masanari Shiramoto; Hitoshi Uchiyama; Hidehisa Tachiki; Shin Irie
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

6.  Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates.

Authors:  Rebecca L DiMarco; Daniel R Hunt; Ruby E Dewi; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2017-03-18       Impact factor: 12.479

7.  Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology.

Authors:  Le Sun; Jin Sun; Zhonggui He
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

8.  Effect of Npt2b deletion on intestinal and renal inorganic phosphate (Pi) handling.

Authors:  Kayo Ikuta; Hiroko Segawa; Shohei Sasaki; Ai Hanazaki; Toru Fujii; Aoi Kushi; Yuka Kawabata; Ruri Kirino; Sumire Sasaki; Miwa Noguchi; Ichiro Kaneko; Sawako Tatsumi; Otoya Ueda; Naoko A Wada; Hiromi Tateishi; Mami Kakefuda; Yosuke Kawase; Shuichi Ohtomo; Yasuhiro Ichida; Akira Maeda; Kou-Ichi Jishage; Naoshi Horiba; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2017-11-11       Impact factor: 2.801

9.  Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.

Authors:  Olena Kis; Jason A Zastre; Md Tozammel Hoque; Sharon L Walmsley; Reina Bendayan
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

10.  Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine.

Authors:  Moran Fairstein; Rotem Swissa; Arik Dahan
Journal:  AAPS J       Date:  2013-02-26       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.